Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Experts are expecting strong performance driven by the strong demand of Lilly's blockbuster drugs, particularly its insulin portfolio. However, there are also con